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Abstract Serum transferrin, ovotransferrin and lactoferrin
constitute the most notable members of the transferrin family.
Among their multiple biological functions, they possess an im-
portant antibacterial activity. These proteins can permeate the
Escherichia coli outer membrane, reaching the inner membrane
where they selectively cause permeation of ions, resulting in
dissipation of the electrical potential without a¡ecting the pH
gradient. Similar results were obtained using arti¢cial lipo-
somes, suggesting a direct action of the proteins on the lipid
bilayer, which was mediated by detectable conformational
changes in their structures.
 2003 Federation of European Biochemical Societies. Pub-
lished by Elsevier Science B.V. All rights reserved.
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1. Introduction
Transferrins are an extended family of metal-binding trans-
port proteins with an in vivo preference for ferric iron. They
are single-chain glycoproteins with a molecular weight of
about 80 kDa widely distributed in physiological £uids and
cells of vertebrates. This family includes four subtypes: serum
transferrin, the iron transport protein in the blood of verte-
brates; lactoferrin, ¢rst discovered in milk; ovotransferrin,
from egg white; and melanotransferrin, ¢rst identi¢ed in ma-
lignant melanoma cells. All these proteins are soluble mole-
cules except melanotransferrin, which is bound to the cell
membrane by a glycosyl phosphatidylinositol anchor, al-
though it can also be secreted [1].
These molecules have very frequently been considered
transport proteins because of their high a⁄nity for iron. How-
ever, they are also implicated in many other important phys-
iological processes. Serum transferrin plays a role in the stim-
ulation of cell proliferation [2] ; it can also act as an insulin
antagonist, producing acute hyperglycemia in normoglycemic
rats and ketonuria in diabetic rats [3] ; it is also involved in
tumoral processes, correlating with severity of disease [4] and
promoting endothelial cell migration and invasion [5]. Ovo-
transferrin is a chicken serum protein whose levels increase in
the acute phase of in£ammation and infection [6] ; its expres-
sion appears correlated with some di¡erentiation processes [7],
and shows antiviral [8] and antibacterial activities [9]. Lacto-
ferrin has been detected at very high concentrations in human
colostrum [10], tears [11] and di¡erent mucosal secretions [12].
Lactoferrin is involved in many aspects of the host defence. It
is released by neutrophils in response to in£ammatory stimuli
that promote the aggregation of these cells [13] ; it is able to
inhibit the growth of solid tumors and the development of
metastases [14] ; it shows antiviral e¡ects [15] ; ¢nally, lacto-
ferrin is able to produce bactericidal or bacteriostatic e¡ects
against a wide variety of Gram-positive and Gram-negative
pathogens [16,17].
Up until now, in spite of the relevance of these glycopro-
teins as part of the ¢rst barrier against pathogen microorgan-
isms, the molecular basis of their antibacterial mechanisms
remains unknown. It has been proposed that some peptides
(lactoferricins, OTAP-92) obtained by hydrolysis could be re-
sponsible for the antimicrobial properties. Nevertheless, those
peptides show di¡erent activities and a wider antimicrobial
spectrum than the native proteins [18^20]. Moreover, in pre-
vious work we described that Lfpep, a synthetic peptide de-
rived from lactoferrin, is bactericidal against Escherichia coli
[21], in contrast to the bacteriostatic activity reported for the
native protein [16,17]. In this report, lactoferrin, serum trans-
ferrin and ovotransferrin are shown to produce analogous
e¡ects when acting either on E. coli cells or on synthetic
vesicles, carrying out selective permeation of ions. The result-
ing alteration of the pre-existing electrochemical gradients
could constitute a molecular explanation for the antibacterial
e¡ects of transferrins.
2. Materials and methods
2.1. Materials
Iron-free lactoferrin, ovotransferrin, serum transferrin, actinomycin
D, nigericin and valinomycin were purchased from Sigma Chemicals.
[14C]Phenylalanine (450 mCi/mmol), [3H]tetraphenylphosphonium (34
Ci/mmol), [3H]uridine (27 mCi/mmol), [14C]acetic acid (62 mCi/
mmol), [14C]methylinulin (20 mCi/mmol) and tritiated water (5 mCi/
ml) were purchased from Amersham. E. coli phospholipids were from
Avanti Polar Lipids. 3,3P-Dipropylthiadicarbocyanine iodide (diS-C3-
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(5)) and 8-hydroxypyrene-1,3,6-trisulfonic acid (pyranine) were pur-
chased from Molecular Probes Europe BV. Brain heart infusion (BHI)
was supplied by Difco.
Purity of transferrin solutions was con¢rmed by gel ¢ltration
(Superose 12 HR 10/30, Pharmacia) and Western blotting with goat
anti-lactoferrin (Immunoresearch Laboratories), rabbit anti-lysozyme
and anti-transferrin antibodies (Sigma).
2.2. Outer membrane permeability assays
E. coli was obtained as described [21]. Alterations to the outer
membrane permeability were tested as previously reported [25]. Cells
were resuspended in the minimal medium M9 and adjusted to
A600 = 0.8. Experiments were performed at 37‡C and under continuous
shaking. Changes in the outer membrane permeability were deter-
mined in transferrin-treated (20 WM) and in non-treated cells, mea-
suring the incorporation of [14C]phenylalanine (10 WCi/ml) into pro-
teins in the presence or absence of a subinhibitory concentration of
actinomycin D (80 Wg/ml). Aliquots of 0.5 ml were extracted, precipi-
tated with 5 ml 5% trichloroacetic acid on ice, ¢ltered through cellu-
lose nitrate ¢lters (0.45 nm pore size) and the radioactivity measured.
2.3. Inner membrane permeability assays
Permeabilization of the bacterial inner membrane was studied de-
termining the e¥ux of [3H]uridine previously accumulated into E. coli
cells. A bacterial suspension (A600 = 0.5) in BHI was incubated with
rifampicin (50 Wg/ml) at 37‡C for 5 min. [3H]Uridine (1 WCi/ml) was
added and the incubation continued for 15 min. Cells were then
washed twice and resuspended in the same initial volume of medium.
0.5 ml aliquots of transferrin-treated (20 WM) and non-treated bacte-
rial suspensions were extracted at di¡erent times, ¢ltered through
cellulose nitrate ¢lters (0.45 nm), and the radioactivity measured.
2.4. Atomic emission spectrometry
E. coli cells were harvested, washed three times and resuspended
(A600 = 2) in deionized Milli-Q water. Cells were incubated at 37‡C for
20 min in the presence or absence of transferrins (20 WM). Aliquots
(2 ml) were centrifuged at 8000Ug for 1 min, the supernatants col-
lected, and [Kþ] and [Naþ] quanti¢ed using an atomic emission spec-
trometry detector (UNICAM 929, Unicam Limited, Cambridge, UK).
Controls containing only Milli-Q water or lactoferrin were performed
independently.
2.5. Determination of E. coli v8, vpH and proton-motive force (vp)
E. coli cells were harvested, washed three times and resuspended
(A600 = 0.8). v8 and vpH of glucose-energized cells were measured
from the distributions of [3H]tetraphenylphosphonium bromide and
[14C]acetic acid, respectively, as described [21]. E. coli vp was calcu-
lated using the general ion electrochemical equation: vp=v83(RT/
F)vpH.
2.6. Preparation of liposomes
Small unilamellar vesicles (SUVs) from E. coli phospholipids were
prepared as described [21]. Total lipids from E. coli were mixed in
chloroform:methanol (9:1 v/v) and extensively evaporated. For bind-
ing and transmembrane electrical potential assays, dried phospholip-
ids were resuspended in 50 mM potassium phosphate bu¡er (pH 6.0)
to obtain a ¢nal lipid concentration of 20 mg/ml. The suspensions
were sonicated, kept in an ice bath, using a titanium tip ultrasonicator
to obtain SUVs. Titanium debris was removed by centrifugation. To
study vpH changes, pyranine-containing SUVs were prepared using a
pyranine bu¡er solution (20 mM potassium phosphate, pH 6.0; 100
mM potassium acetate; 100 WM pyranine). Non-encapsulated £uores-
cent probe was separated from the vesicle suspension using a Sepha-
dex G-50 gel ¢ltration column (25U0.5 cm) and eluted with 20 mM
potassium phosphate bu¡er (pH 6.0) containing 100 mM K-PIPES.
When required, strictly isotonic conditions were ensured by checking
the osmotic pressure of intra- and extravesicular solutions in a Osmo-
mat 30 osmometer (Gonotec, Berlin, Germany). Phospholipid concen-
trations were determined by inorganic phosphorus analysis.
2.7. Monitoring of transmembrane v8 and vpH in liposomes
Changes in pre-established v8 and vpH in liposomes were moni-
tored at 25‡C as previously described [22]. The reaction mixtures
(1 ml) were prepared by diluting liposomes (1/100) in 50 mM potas-
sium phosphate bu¡er (pH 7.2) and adding the £uorescent potential
sensitive dye diS-C3-(5) at a ¢nal concentration of 1 WM. When re-
quired, a transmembrane Kþ di¡usion potential (negative inside) was
generated in the phospholipid vesicles by addition of valinomycin
(1 WM). Alterations in the electrical potential of E. coli liposomes
directly treated and not treated with lactoferrin (ranging from 0.01
to 40 WM) were continuously monitored by the £uorescence quench-
ing of diS-C3-(5) using a Perkin Elmer LS 50 spectro£uorometer.
Experiments were performed at 25‡C at excitation and emission wave-
lengths of 616 nm and 676 nm respectively.
The internal pH (pHi) of liposomes was monitored from the £uo-
rescence of pyranine entrapped within the liposomes. Liposomes were
previously 100-fold diluted in 20 mM potassium phosphate containing
100 mM K-PIPES (pH 7.8) for the generation of a pH gradient.
Fluorescence of vesicles treated and not treated with lactoferrin (rang-
ing from 0.01 to 40 WM) was monitored at excitation and emission
wavelengths of 450 nm and 508 nm respectively. The assays were
carried out at 25‡C.
2.8. Far-UV circular dichroism (CD) spectroscopy
Determinations of transferrins CD spectra were performed in 50
mM potassium phosphate bu¡er (pH 7.2) in the presence or absence
of liposomes using a Jasco J-500A spectropolarimeter. The spectra
were the average of eight scans obtained using a quartz optical cell
with pathlength of 0.1 mm at room temperature. When required,
compensations for the scattering were performed by subtracting the
CD spectra measured for liposomes. The data were expressed as mean
residue ellipticity (degrees cm2/dmol). Concentrations of protein and
phospholipids were 50 WM and 4 mM, respectively.
2.9. Intrinsic tryptophan £uorescence measurements
Transferrins were added to SUVs at a ¢xed phospholipid:protein
ratio (15:1, mol/mol). No corrections were made for changes in os-
molarity as little change in 90‡ light scattering indicated little change
in vesicle structure. Small aliquots of the stock solutions of quenchers
(4 M KI, 3 M acrylamide) were added and £uorescence measured as
described [21]. Since excitation at 280 and 295 nm showed very similar
results, 295 nm was used in order to minimize tyrosine e¡ects. The
Fig. 1. E¡ect of transferrins on [14C]phenylalanine incorporation into proteins in the presence or absence of actinomycin D. Control (a) ; acti-
nomycin D (R) ; transferrins (E) ; actinomycin D+transferrins (F). A: Lactoferrin. B: Ovotransferrin. C: Serum transferrin.
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£uorescence was recorded in a range from 310 to 380 nm, and inten-
sity at the Vmax used for Stern^Volmer plots. F and F0 are the £uo-
rescence intensities with and without quencher respectively.
3. Results
3.1. Transferrins alter E. coli outer and inner membrane
permeabilities
The ability of serum transferrin, ovotransferrin and lacto-
ferrin to disturb the E. coli outer membrane permeability was
assayed using actinomycin D. This hydrophobic antibiotic,
bactericidal for Gram-positive bacteria, possesses a limited
action against Gram-negative bacteria due to the outer mem-
brane charged lipopolysaccharides. No e¡ect on protein bio-
synthesis was observed in assays performed in the presence of
a subinhibitory concentration of actinomycin D or serum
transferrin, ovotransferrin and lactoferrin in the absence of
actinomycin D, in separate assays. Nevertheless, simultaneous
addition of actinomycin D and any of the transferrins inhib-
ited about 50% of the protein synthesis, indicating an in-
creased outer membrane permeabilization for the drug (Fig. 1).
Permeabilization of the inner membrane was assessed by
determining the leakage of previously accumulated [3H]uri-
dine in E. coli cells. No e¥ux of the previously accumulated
[3H]uridine in the presence of any of the transferrin molecules
could be measured (data not shown). Interestingly, atomic
emission spectrometry determinations showed that the addi-
tion of serum transferrin, ovotransferrin or lactoferrin to the
cells increased the extracellular Kþ concentration to 0.6U 0.1
ppm without any signi¢cant e¡ect on Naþ. These changes in
ion concentration had no e¡ect on E. coli viability.
3.2. Transferrins dissipate E. coli electrical potential (v8)
Ion concentration changes should have consequences on the
transmembrane v8. Addition of serum transferrin, ovotrans-
ferrin or lactoferrin to the cell suspensions resulted in a rapid
reduction and even abolition of v8 (Table 1). The v8 dis-
sipation was dependent on the protein concentration. Above
50% reduction of v8 was achieved at 0.13 WM lactoferrin and
1.8 WM serum transferrin and ovotransferrin, while the abo-
lition was reached at 6.4 WM lactoferrin, 13 WM ovotransferrin
and 26 WM serum transferrin. On the other hand, determina-
tions of the transmembrane pH gradient (vpH) showed that
transferrins produced only slight internal alkalinization
(9 0.15 units). After applying these data to the general ion
electrochemical equation, the proton motive force (estimated
to be 3198 mV in control assays) was decreased signi¢cantly
to 356 mV after the addition of the proteins at an external
pH of 7.5 and at 25‡C.
3.3. Transferrins produce selective ion permeabilization on
liposomes
Di¡erential ion concentration changes and v8 dissipation
without signi¢cant alteration of vpH suggested a selective
inner membrane permeabilization mediated by transferrins.
This hypothesis was veri¢ed using arti¢cial vesicles with an
imposed v8 (negative inside). v8 was generated by diluting
Kþ-loaded liposomes in Naþ-phosphate bu¡er, and then hy-
perpolarizing them by addition of the Kþ ionophore valino-
mycin (1 WM). The e¡ect of transferrins on this v8 was moni-
tored using the £uorescent potential-sensitive dye diS-C3-(5).
In separate experiments, additions of serum transferrin, ovo-
transferrin or lactoferrin at concentrations from 0.01 to 40
WM did not dissipate v8. However, later addition of the cat-
ion ionophore nigericin (1 WM) shifted the £uorescence signal,
indicating the abolition of v8 (Fig. 2).
Interestingly, addition of any of the transferrins to liposome
suspensions in which v8 was not previously created by vali-
nomycin gave rise to immediate £uorescence quenching (Fig.
3), indicating the generation of v8 across the lipid bilayer.
The minimal concentrations of serum transferrin, ovotransfer-
rin or lactoferrin necessary to reach complete bilayer hyper-
polarization were 1.6, 1.2 and 0.6 WM respectively. Later ad-
dition of valinomycin to the transferrin-hyperpolarized
vesicles had no e¡ect on v8, although v8 could be abolished
by addition of nigericin.
It is noteworthy that £uorescence quenching was not ob-
served after the addition of lactoferrin, ovotransferrin or se-
rum transferrin to liposomes in which the location of ions was
exchanged (Naþ inside, Kþ outside), indicating that transfer-
rins were not able to establish a v8 in these conditions (data
not shown).
Hþ permeation by the e¡ect of transferrins was determined
using liposomes in which a vpH was preformed and contain-
ing pyranine as internal pH indicator. None of the molecules
Table 1
E¡ect of transferrins on E. coli v8
[Protein] (WM) v8 (mV)
Lactoferrin Ovo-
transferrin
Serum
transferrin
0 3110U 11 3110U 11 3110U 11
0.013 371U 5 388U 4 397U 5
0.13 350U 4 379U 8 395U 5
0.64 331U 5 368U 6 375U 4
1.8 315U 2 330U 3 340U 3
3.2 37U 3 320U 2 325U 3
6.4 0 36U 1 313U 3
13 0 0 38U 2
26 0 0 0
38.4 0 0 0
Fig. 2. E¡ect of transferrins on valinomycin-hyperpolarized lipo-
somes. Serum transferrin, ovotransferrin or lactoferrin at 40 WM
were added at indicated times. 1 WM nigericin (Nig) was used to
abolish the electrical potential created by transferrins. Under the ex-
perimental conditions assayed, nigericin acts as a general cation ion-
ophore (see Section 4).
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was able to alter vpH, which could be abolished by nigericin
(data not shown).
3.4. Transferrin-mediated ion permeation is accompanied by
conformational changes
Changes in transferrin secondary structure induced by bind-
ing to liposomes were analyzed by far-UV CD. Lactoferrin
exhibited the most marked di¡erences, mainly at 200 and 212
nm, while very similar spectra were recorded for serum trans-
ferrin both in soluble and in bound form. Ovotransferrin
showed intermediate di¡erences (Fig. 4).
Tryptophan intrinsic £uorescence was also used to deter-
mine binding-induced alterations in transferrin structures. Ex-
posure of tryptophanyl residues from serum transferrin, ovo-
transferrin or lactoferrin to low molecular weight quenchers in
the presence and absence of vesicles was examined. The e⁄-
ciency of the ionic quencher I3 varied in aqueous suspen-
sions; it was notably high for serum transferrin and, espe-
cially, for lactoferrin. However, the e⁄ciency of the
quencher was lower for ovotransferrin (Fig. 5). In all cases,
addition of liposomes resulted in a decrease of the I3 quench-
ing e¡ect. In di¡erent experiments, we used the polar (non-
ionic) molecule acrylamide as the quenching agent. The acces-
sibility of tryptophanyl residues to acrylamide displayed re-
markable changes in the presence of E. coli liposomes (Fig. 5).
Exposure of the tryptophan residues to the quenching agent
was considerably increased.
4. Discussion
The transferrin family includes proteins that perform many
biological activities, including a physiological role in the de-
Fig. 3. Hyperpolarization of liposomes by e¡ect of transferrins. Se-
rum transferrin, ovotransferrin or lactoferrin at 0.6 WM and 1 WM
nigericin (Nig) were added at indicated times.
Fig. 4. CD spectra of transferrins in aqueous solution (continuous
line) and in the presence of liposomes (dotted line). A: Lactoferrin.
B: Ovotransferrin. C: Serum transferrin.
Fig. 5. Stern^Volmer plots for transferrins in the presence (b) or absence (F) of liposomes using acrylamide (A^C) or iodine (D^F) as quench-
ers. A,D: Lactoferrin. B,E: Ovotransferrin. C,F: Serum transferrin.
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fence against microbial infections. This report shows that the
most signi¢cant members of this family are able to act on
biological membranes in a closely related manner. This mech-
anism could constitute the molecular basis of the antibacterial
activity of the transferrin family.
Interaction of the transferrins with the anionic E. coli outer
membrane can be hypothesized due to the remarkable cationic
nature of these molecules. This subject was studied using the
hydrophobic antibiotic actinomycin D, able to inhibit RNA
synthesis, bactericidal against Gram-positive bacteria but with
a restricted e¡ect against Gram-negative bacteria due to the
charged lipopolysaccharides. Neither the addition of any of
the transferrins nor the antibiotic produced any detectable
change in protein biosynthesis. However, their simultaneous
addition allowed the permeation of actinomycin D through
the outer membrane, so inhibiting RNA and protein synthe-
sis, showing a permeabilization e¡ect on the outer membrane
mediated by transferrins.
Assays to detect inner membrane permeabilization were
also performed. Exposure to serum transferrin, ovotransferrin
or lactoferrin did not allow the e¥ux of previously accumu-
lated [3H]uridine, indicating the inability of these proteins to
cause extensive damage. Nevertheless, spectrometric determi-
nations showed a marked increase in extracellular [Kþ] in-
duced by these proteins, without any detectable changes in
[Naþ]. These results could indicate a permeabilization of
ions that would have an important e¡ect on the transmem-
brane ionic gradients. In fact, in vivo determinations of v8 on
E. coli cells showed that transferrins were able to produce a
rapid membrane depolarization. Nevertheless, contrary to our
expectations, these proteins were not able to dissipate the
transmembrane vpH.
Actually, a slight internal cell alkalinization was detected
resulting in a small increase in vpH. Our results point to a
selective permeation of some ions through the inner mem-
brane mediated by transferrins. This event produced a bacter-
iostatic e¡ect without a¡ecting E. coli viability in agreement
with previous reports [16].
To demonstrate the selective ion permeation, we used arti-
¢cial membrane systems. Addition of serum transferrin, ovo-
transferrin or lactoferrin to Kþ-loaded liposomes diluted in
Naþ bu¡er had no e¡ect when a previous v8 was generated
by the Kþ ionophore valinomycin. However, v8 could be
dissipated by Naþ permeation mediated by the cation iono-
phore nigericin. Nigericin is a water-insoluble polyether anti-
biotic and mainly, but not strictly, a potassium/proton ex-
changer. Nigericin can also complex (although with less
a⁄nity) rubidium, sodium, cesium and lithium. In a situation
when a single cation predominates, the cation is exchanged for
Hþ. Under the conditions tested, sodium is the cation that
predominates outside the liposome.
Addition of valinomycin to the system allowed Kþ e¥ux
from the liposome, therefore creating a v8 negative inside the
liposome. Under the assayed conditions, following addition of
nigericin should lead to an electroneutral Naþ/Hþ exchange.
However, according to Donnan equilibrium, movement of
ions through a membrane is ruled by the charge distribution
across the membrane and the concentration. Both factors con-
tribute to a favorable release of Naþ ions inside the liposome.
However, the movement of Hþ from the inside to the outside
of the liposome against the concentration gradient (pH is the
same at both sides of the membrane) and charge (negative
inside the liposome) is thermodynamically less favorable.
Under these conditions, the observable e¡ect upon addition
of nigericin is a dissipation of v8 created by valinomycin [22].
Interestingly, transferrins were able to generate a v8 when
directly added to Kþ-loaded liposomes. Later addition of va-
linomycin produced no further e¡ects; however, this v8
could be dissipated by nigericin. Moreover, none of the trans-
ferrins was capable of establishing a v8 after their addition to
Naþ-loaded liposomes diluted in Kþ bu¡er, nor to modify a
previously generated vpH. These results show that transfer-
rins act directly on a lipid bilayer selectively permeating ions
such as Kþ and excluding others such as Naþ or Hþ. These
data correlate with those obtained for living cells, and support
a molecular explanation for them.
Serum transferrin, ovotransferrin and lactoferrin are soluble
proteins. Interaction with the cell inner membrane should in-
volve some sort of conformational changes. Alterations in the
secondary structure were determined by far-UV CD. An in-
crease in the K-helical content for the liposome-bound lacto-
ferrin and, to a lesser extent, for ovotransferrin was observed.
Lactoferrin, ovotransferrin and serum transferrin contain
10 conserved tryptophan residues. The presence of an aro-
matic indole group in this amino acid allows for the use of
its intrinsic £uorescence to observe protein structural changes.
Modi¢cations of the intrinsic tryptophan £uorescence inten-
sity and of the maximum emission wavelength evidence
changes in the amino acid’s physico-chemical surroundings
due to the protein^liposome binding, protein structural
changes or both phenomena [23]. Protein folding alterations
result in the burial of certain amino acid residues from the
external aqueous environment and/or exposure of other ami-
no acids previously buried. It is possible to check this sort of
modi¢cations by registering di¡erences of tryptophan accessi-
bility to low molecular weight £uorescence quenching agents.
In proteins and peptides having only one tryptophanyl residue
in their amino acid sequence, the £uorescence emission of the
molecule is decreased in a linear way upon increasing the
concentration of the quenching agent. Quenching patterns
for most multi-tryptophan-containing proteins are di⁄cult
to analyze, but qualitative information can, nevertheless, be
extracted [23]. All the transferrins analyzed produced changes
upon binding to liposomes, as shown by a clear decrease of
the quenching mediated by the ionic iodine. Since a protein is
a polyelectrolyte, electrostatic e¡ects, due to the presence of
the basic residues arginine and lysine in the lactoferrin amino
acid sequence £anking the tryptophan molecule, might in£u-
ence the potassium iodide quenching e¡ect [24]. Acrylamide is
a polar, non-ionic molecule and does not share the features of
KI. It is able to sense the exposure of residues in a purely
random fashion [23]. Stern^Volmer plots carried out in the
presence of the polar, non-ionic acrylamide showed an in-
creased £uorescence quenching in all cases, which eliminates
the possibility that the observed e¡ects could be exclusively
mediated by binding to liposomes.
In summary, in this report we describe a molecular mech-
anism common to all transferrins studied that can constitute
the basis of their antimicrobial e¡ect. Serum transferrin, ovo-
transferrin and lactoferrin are able to permeate the E. coli
outer membrane and to access the inner membrane, where
they cause permeation of ions in a selective manner. This
e¡ect can be measured both in cells and in arti¢cial mem-
branes, and allows the selective permeabilization of at least
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Kþ, without any action on Naþ or Hþ, although action on
other ions must be considered and would need future analysis.
The consequence is an in vivo dissipation of v8 without a
signi¢cant alteration of vpH and a decrease of the electro-
chemical potential from 3198 mV to 356 mV. As a result
of the uncoupling of the respiration-dependent energy produc-
tion, bacteria enter bacteriostasis.
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